Current Issue
Clinical Focus: PROTOCOLS AND TREATMENT OPTIONS FOR CARDIOVASCULAR DISEASE Volume: 124 Number: 2
Month: Mar 2012
Featured Articles:
- Acute Coronary Syndromes: Identifying the Appropriate Patient for Prasugrel - John C. Stephens, MD, FACC; Arman T. Askari, MD, FACC
- Hyponatremia, Heart Failure, and the Role of Tolvaptan - John B. O’Connell, MD; Addis Alemayehu, PharmD
- The Role of ARBs Alone or with HCTZ in the Treatment of Hypertension and Prevention of Cardiovascular and Renal Complications - Mark K. Greathouse, MD; Matthew R. Weir, MD
- Managing Diabetes with Integrated Teams: Maximizing Your Efforts with Limited Time - Davida F. Kruger, MSN, APN-BC, BC-ADM; Gayle M. Lorenzi, RN, CDE; Betsy B. Dokken, NP, PhD; Christopher E. Sadler, MA, PA-C, CDE; Kelly Mann, MSN, FNP-BC, CDE; Virginia Valentine, CNS, BC-ADM, CDE, FAADE
- Health Care Utilization and Costs in Type 2 Diabetes Mellitus and Their Association with Renal Impairment - James Burke, PhD; Birgit Kovacs, MD; Leigh Borton, BA; Stephen Sander, PhD
- Medical Management of Diabetic Foot Infections - Mazen S. Bader, MD; Annie Brooks, RPh, BScPhm
- Tolerability of Concomitant Use of Selective Serotonin Reuptake Inhibitors or Serotonin–Norepinephrine Reuptake Inhibitors and Oxymorphone Extended Release - John H. Peniston, DO; Xiaojun Hu, PhD; Susan L. Potts, MS; Matthew S. Wieman, MD; Dennis C. Turk, PhD
- Vasodilating Versus First-Generation β-Blockers for Cardiovascular Protection - Hassan Fares, MD; Carl J. Lavie, MD, FACC; Hector O. Ventura, MD, FACC
- Investigation of End-Digit Preference in Blood Pressure Records of Hospitalized Chinese Patients and Analysis of Risk Factors - Gu Jie, MD; Wang Jian, MD; Huang Qiaowen, MD; Zhu Shanzhu, MD
- Different Treatment Interventions Affect Plasma NT-ProBNP Levels and Early Exercise Tolerance in Patients with Acute ST-Segment Elevation Myocardial Infarction - Xiao-lin Wu, MD; Rui Zhu, MD; Hong Jiang, PhD; Bin Li, PhD
- Tumor Lysis Syndrome: A Systematic Review of Case Series and Case Reports - Belal M. Firwana, MD; Rim Hasan, MD; Nour Hasan, MD; Fares Alahdab, MD; Iyad Alnahhas, MD; Seba Hasan, MD; Joseph Varon, MD, FACP, FCCP, FCCM
Articles from 2012
- Recent Advancements in the Treatment of Resistant Hypertension
- Investigation of End-Digit Preference in Blood Pressure Records of Hospitalized Chinese Patients and Analysis of Risk Factors
- The Role of ARBs Alone or with HCTZ in the Treatment of Hypertension and Prevention of Cardiovascular and Renal Complications
- Acute Coronary Syndromes: Identifying the Appropriate Patient for Prasugrel
- Vasodilating Versus First-Generation β-Blockers for Cardiovascular Protection
